Systematic Identification of Molecular Targets and Pathways Related to Human Organ Level Toxicity

Tuan Xu1, Leihong Wu2, Menghang Xia1

  • 1Division of Preclinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Rockville, Maryland 20850, United States.

Insights

This study identifies key genes and biological pathways involved in chemical toxicity across eight organ systems. These findings advance our understanding of toxicity mechanisms and support the development of new toxicity testing methods.

Area of Science:

  • Toxicology
  • Computational Biology
  • Genomics

Background:

  • Mechanisms of organ-level toxicity are not well understood.
  • Predicting chemical toxicity requires identifying molecular targets and pathways.

Purpose of the Study:

  • To identify molecular targets and biological pathways for eight common organ toxicity endpoints.
  • To create a foundation for improved in vitro toxicity testing and Adverse Outcome Pathway (AOP) development.

Main Methods:

  • Integrated analysis of in vitro assay data, literature-mined pathway annotations, and text-mined toxicity-gene associations.
  • Application of machine learning techniques to identify molecular targets for specific toxicities.
  • Analysis of 1516 identified toxicity-related genes for biological pathway coverage.

Main Results:

  • Identified 1516 toxicity-related genes and 206 significant biological pathways (p<0.05).
  • Pathway coverage varied per toxicity endpoint, from 3 for developmental toxicity to 101 for skin toxicity.
  • Generated molecular targets for carcinogenicity, cardiotoxicity, developmental toxicity, hepatotoxicity, nephrotoxicity, neurotoxicity, reproductive toxicity, and skin toxicity.

Conclusions:

  • This systematic analysis provides a comprehensive resource of molecular targets and pathways for various in vivo toxicities.
  • The findings can guide the design of more efficient in vitro toxicity assays and aid in AOP development.
  • Results offer numerous testable hypotheses for future experimental validation.

Related Concept Videos

Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.6K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.7K
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.6K